A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura

Transfusion Medicine

Volumn 17, Issue 1, 2007, Pages 17-35

  Brunskill, S J ^a   Tusold, A ^a   Benjamin, S ^a,b   Stanworth, S J ^b   Murphy, M F ^a,b,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Plasma exchange; Thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; FRESH FROZEN PLASMA; RITUXIMAB;

CLINICAL TRIAL; CONFIDENCE INTERVAL; CRYOPRECIPITATION; DATA ANALYSIS; DATA EXTRACTION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MORTALITY; PLASMA TRANSFUSION; PLASMAPHERESIS; QUALITY CONTROL; QUALITY OF LIFE; REMISSION; REVIEW; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME;

BLOOD TRANSFUSION; DETERGENTS; FACTOR VIII; FIBRINOGEN; HUMANS; METHYLENE BLUE; PLASMA; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION; RESEARCH DESIGN; SINGLE-BLIND METHOD; SOLVENTS; TREATMENT OUTCOME;

EID: 33846912961     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2006.00720.x     Document Type: Review

References (42)

1. Ahmad, A., Aggarwal, A., Sharma, D., Dave, H.P., Kinsella, V., Rick, M.E. & Schechter, G.P. (2004) Rituximab for treatment of refractory/relapsing thrombotic thromboocytopenic purpura (TTP). American Journal of Haematology, 77, 171-176.
2. Allford, S.L., Hunt, B.J., Rose, P. & Machin, S.J.; for the Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. British Journal of Haematology, 120, 556-573.
3. Alvarez-Larran, A., Del Rio, J., Ramirez, C. et al. (2004) Methylene blue-phoyoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sanguinis, 86, 246-251.
4. Bobbio-Pallavicini, E., Gugliotta, L., Centurioni, R., Porta, C., Vianelli, N., Billio, A., Tacconi, F. & Ascar, E.; for the Italian co-operative group for TTP. (1997) Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomised multicenter trial by the Italian Co-operative Group for TTP. Haematologica, 82, 429-435.
5. Buskard, N.; for the Canadian Apheresis Study Group (CASG). (1992) Treatment of thrombotic thrombocytopenic purpura (TTP). [abstract S4.]. Transfusion Medicine, 2, 73.
6. Elliott, E., Ridley, G., Hodson, E. & Crais, J. (2002) Interventions for established haemolytic uraemic syndrome/ thrombotic thrombocytopenic purpura. (Protocol) Cochrane Database of Systematic Reviews. Art. No.: CD003595. DOI: 10.1002/14651858.CD003595.
7. Furlan, M., Robles, R., Solenthaler, M., Wassmer, M., Sandoz, P. & Lammle, B. (1997) Deficient activity of von Willebrand factor - cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 89, 3097-3103.
8. George, J.N. (2004) The Oklahoma thrombotic thrombocytopenic purpura-haemolytic uremic syndrome registry: a program for patient care, education and research. Transfusion, 44, 1384-1392.
9. George, J.N., Woodson, R.D., Kiss, J.E., Kojouri, K. & Vesely, S.K. (2006) Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the transfusion medicine/haemostatsis clinical trials network with a systematic review of rituximab therapy for immune-medicated disorders. Journal of Clinical Apheresis, 21, 49-56.
10. Harrison, C.N., Lawrie, A.S., Iqbal, A., Hunter, A. & Machin, S.J. (1996) Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura. British Journal of Haematology, 94, 756-758.
11. Hellstern, P. (2004) Solvent/detergent-treated plasma: composition, efficacy, and safety. Current Opinion in Haematology, 11, 346-350.
12. Henon, P. (1992) Thrombotic thrombocytopenic purpura: clinical results of a French controlled trial. Transfusion Science, 13, 63-72.
13. Horowitz, M.S. & Pehta, J.C. (1998) SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sanguinis, 74 (Suppl. 1), 231-235.
14. Howard, M.A., Williams, L.A., Terrell, D.R., Duvall, D., Vesely, S.K. & George, J.N. (2006) Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-haemolytic uremic syndrome [letter]. Transfusion, 46, 154-156.
15. Levy, G.G., Nichols, W.C., Lian, E.C. et al. (2001). Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488-494.
16. Lian, E. (2005) Pathogenesis of thrombotic thrombocytopenic purpura:ADAMTS13 and beyond. Seminars in Thrombotic Haemostasis, 31, 625-632.
17. McMinn, J.R., Thomas, I.A., Terrell, D.R., Duvall, D., Vesley, S.K. & George, J.N. (2003) Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-haemolytic uremic syndrome: a study of 78 additional patients [letter]. Transfusion, 43, 415.
18. Mintz, P.D., Neff, A., Mackenzie, M. et al. (2004) Therapeutic plasma exchange (TPE) for thrombotic thrombocytopenic purpura (TTP) using plasma prepared with photochemical treatment (INTERCEPT) plasma. (2004) Blood (American Society of Haematology Abstracts), 104, 838.
19. Novitzky, N., Jacobs, P. & Rosenstrauch, W. (1994) The treatment of thrombotic thrombocytopenic purpura: plasma infusion or plasma exchange? British Journal of Haematology, 87, 317-320.
20. Owens, M.R., Sweeney, J.D., Tahhan, R.H. & Fortkolt, P. (1995) Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura. Journal of Clinical Apheresis, 10, 178-182.
21. Pehta, J., Horowitz, M.S. & the S/D Plasma study group. (1994) On-going clinical studies with solvent detergent treated plasma in patients with acute thrombotic thrombocytopenic purpura. [abstract 2668]. Blood, 84, 671a.
22. Pereira, A., Mazzara, R., Monteagudo, J., Sanz, C., Puig, L., Martinez, A., Ordinas, A. & Castillo, R. (1995) Thrombocytopenic purpura/haemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Annals of Haematology, 70, 319-323.
23. Raife, T.J., Friedman, K.D. & Dwyre, D.M. (2006) The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryo-poor plasma. Transfusion, 46, 74-79.
24. Rizvi, M.A., Vesely, S.K., George, J.N., Chandler, L., Duvall, D., Smith, J.W. & Gilcher, R.O. (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-haemolytic-uremic syndrome. Transfusion, 40, 896-901.
25. Robinson, K.A. & Dickersin, K. (2003) Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology, 31, 150-153.
26. Rock, G. (2005) The management of thrombotic thrombocytopenic purpura in 2005. Seminars in Thrombosis and Haemostasis, 31, 709-713.
27. Rock, G. & the Members of the Canadian Apheresis Group. (1993) Plasma exchange in thrombotic thrombocytopenic purpura (TTP). [abstract P10]. Transfusion Medicine, 3 (Suppl. 1), 9.
28. Rock, G., Shumak, K., Kelton, J., Blanchette, V.S., Buskard, N., Nair, R., Spasoff, R. & the Canadian Apheresis Study Group. (1992) Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Transfusion, 32, 710-714.
29. Rock, G., Anderson, D., Clark, W. et al. (2005) Does cryosupernatent plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet. British Journal of Haematology, 129, 79-86.
30. Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nair, R.C., Spasoff, R.A. & the Canadian Apheresis Study Group. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. New England Journal of Medicine, 325, 393-397.
31. Rock, G.A., Shumak, K.H., Sutton, D.M., Buskard, N.A. & Nair, R.C. (1996) Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. British Journal of Haematology, 94, 383-386.
32. Rothele, E., Krumme, B. & Rump, L.C.; for the PRODROMI Study Group. (2000) Design of the prospective randomised study for the treatment of patients with thrombotic microangiopathy. Therapeutic Apheresis, 4, 327-331.
33. de la Rubia, J., Arriaga, F., Linares, D., Larrea, L., Carpio, N., Marty, M.L. & Sanz, M.A. (2001) Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 114, 721-723.
34. Sacher, R., Pehta, J., Zarou, C., Moake, J. & the SDP Study Group (1996) Solvent detergent-treated plasma versus fresh frozen plasma in patients with thrombotic thrombocytopenic purpura. [abstract S252]. Transfusion, 36 (Suppl. 95).
35. Salge-Bartels, U., Bretiner-Ruddock, S., Hunfeld, A. & Heiden, M. (2006) Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe? Transfusion Medicine, 16, 266-275.
36. Schulz, K.F., Chalmers, I., Hayes, R.J. & Altman, D. (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association, 273, 408-412.
37. Shepard, K.V., Fishleder, A., Lucas, F.V., Goormastic, M. & Bukowski R.N. (1991) Thrombotic thrombocytopenic purpura treated with plasma exchange or exchange transfusions. Western Journal of Medicine, 154, 410-413.
38. Shumak, K.H., Rock, G.A., Nair, R.C. & the Canadian Apheresis Group. (1995) Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Annals of Internal Medicine, 122, 569-572.
39. Von Bayer, H. (2003) Plasmapheresis in immune haematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience. Therapeutic Apheresis and Dialysis, 7, 127-140.
40. Yarranton, H., Cohen, H., Pavord, S.R., Benjamin, S., Hagger, D. & Machin S.J. (2003) Venous thromboembolism associated with the management of thrombotic thrombocytopenic purpura. British Journal of Haematology, 11, 778-785.
41. Yomtovian, R., Niklinski, W., Silver, B., Sarode, R. & Tsai, H.M. (2004) Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. British Journal of Haematology, 124, 787-795.
42. Zeigler, Z.R., Shadduck, R.K., Gryn, J.F. et al. (2001) Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). Journal of Clinical Apheresis, 16, 19-22.